ELF3 and neoplasm: Overexpression of AGR2 was associated with advanced clinical stage, advanced tumor, but a better prognosis based on the TCGA database and KM‐plotter database in PDAC (Figure S4A‐C), suggesting a complex effect of AGR2 on cancer growth and survival resembling that of ESE1.